🇺🇸 FDA
Pipeline program

COVID-19 Vaccine (Vero Cell), Inactivated (Medium-dose)

PRO-nCOV-2004

Phase 2 mab terminated

Quick answer

COVID-19 Vaccine (Vero Cell), Inactivated (Medium-dose) for COVID-19 is a Phase 2 program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
SINOVAC BIOTECH LTD
Indication
COVID-19
Phase
Phase 2
Modality
mab
Status
terminated

Clinical trials